🇺🇸 FDA
Patent

US 12049457

Highly purified pharmaceutical grade tasimelteon

granted A61PA61P25/20

Quick answer

US patent 12049457 (Highly purified pharmaceutical grade tasimelteon) held by VANDA PHARMACEUTICALS INC. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VANDA PHARMACEUTICALS INC.
Grant date
Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P25/20